Beth Darnall, PhD, is professor of anesthesiology, perioperative, and pain medicine at Stanford University School of Medicine and director of the Stanford Pain Relief Innovations Lab. A pain psychologist-scientist, she leads NIH and PCORI-funded multisite and national studies on scalable behavioral analgesic interventions and patient-centered opioid reduction. Her work centers on developing, investigating, and disseminating solutions that expand access to evidence-based behavioral pain care across populations. She created Empowered Relief(R), a 1-session group intervention that rapidly equips individuals with effective pain relief skills for acute, chronic, and postsurgical pain. Empowered Relief(R) is being delivered in 31 countries and in 9 languages. She is chief science advisor at AppliedVR and helped create the RelieVRx, the first FDA-authorized virtual reality product for chronic low back pain. Dr. Darnall has three times briefed the U.S. Congress and the FDA on patient-centered pain care and opioid stewardship. She was a scientific member of the NIH Interagency Pain Research Coordinating Committee (2020-2025), served on the CDC Opioid Workgroup (2021), and is author of five books for patients and clinicians. Dr. Darnall has delivered keynote presentations at national annual pain society conferences in the United States, Australia, New Zealand, The Netherlands, Switzerland, and the United Kingdom. In 2018 she spoke on the psychology of pain relief at the World Economic Forum in Davos, Switzerland. She is the 2027 President of the United States Association for the Study of Pain. Stanford Faculty Profile and CV: https: //profiles.stanford.edu/beth-darnall Twitter/X: @bethdarnall Website: https: //bethdarnall.people.stanford.edu/

